CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner

CCAAT/enhancer-binding protein δ (C/EBPδ) recently emerged as an essential player in the inflammatory response to bacterial infections. C/EBPδ levels increase rapidly after a proinflammatory stimulus, and increasing C/EBPδ levels seem to be indispensable for amplification of the inflammatory response. Here we aimed to elucidate the role of C/EBPδ in host defense in community-acquired pneumococcal pneumonia. We show that C/EBPδ−/− mice are relatively resistant to pneumococcal pneumonia, as indicated by delayed and reduced mortality, diminished outgrowth of pneumococci in lungs, and reduced dissemination of the infection. Moreover, expression of platelet-activating factor receptor (PAFR), which is known to potentiate bacterial translocation of Gram-positive bacteria, was significantly reduced during infection in C/EBPδ−/− mice compared with WT controls. Importantly, cell stimulation experiments revealed that C/EBPδ potentiates PAFR expression induced by lipoteichoic acid and pneumococci. Thus, C/EBPδ exaggerates bacterial dissemination during Streptococcus pneumoniae-induced pulmonary infection, suggesting an important role for PAFR-dependent bacterial translocation.

[1]  M. Bergeron,et al.  Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice , 1998, Infection and Immunity.

[2]  P. Carmeliet,et al.  Urokinase Receptor Is Necessary for Adequate Host Defense Against Pneumococcal Pneumonia1 , 2002, The Journal of Immunology.

[3]  C. Feldman.  Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. , 2004, The Journal of laboratory and clinical medicine.

[4]  Kleanthis G. Xanthopoulos,et al.  Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors* , 1998, The Journal of Biological Chemistry.

[5]  P. Reitsma,et al.  Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. , 2007, American journal of respiratory and critical care medicine.

[6]  J. Papaconstantinou,et al.  Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. , 1992, The Journal of biological chemistry.

[7]  A. Birukova,et al.  Amifostine reduces lung vascular permeability via suppression of inflammatory signalling , 2009, European Respiratory Journal.

[8]  T. van der Poll,et al.  Platelet-Activating Factor Receptor Contributes to Host Defense against Pseudomonas aeruginosa Pneumonia but Is Not Essential for the Accompanying Inflammatory and Procoagulant Response1 , 2008, The Journal of Immunology.

[9]  T. van der Poll,et al.  Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia , 2008, European Respiratory Journal.

[10]  Mauro M. Teixeira,et al.  Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection , 2009, Proceedings of the National Academy of Sciences.

[11]  M. Bar‐eli,et al.  Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor , 2007, Cancer and Metastasis Reviews.

[12]  H. Patel,et al.  Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes , 1997 .

[13]  T. van der Poll,et al.  The Receptor for Advanced Glycation End Products Impairs Host Defense in Pneumococcal Pneumonia1 , 2009, The Journal of Immunology.

[14]  B. Yard,et al.  Heterogeneity in lipopolysaccharide responsiveness of endothelial cells identified by gene expression profiling: role of transcription factors , 2006, Clinical and experimental immunology.

[15]  S. Gillespie,et al.  Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract. , 1996, Journal of medical microbiology.

[16]  T. Poll,et al.  PNEUMONIA MODELS AND INNATE IMMUNITY TO RESPIRATORY BACTERIAL PATHOGENS , 2005, Shock.

[17]  J. Crawley,et al.  Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Stankova,et al.  Modulation of platelet-activating factor receptor (PAFR) gene expression via NFκB in MonoMac-1 cells , 1997, Inflammation Research.

[19]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Akira,et al.  Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. , 2006, American journal of respiratory and critical care medicine.

[21]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  D. R. Wilson,et al.  Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Lei-Chin Chen,et al.  Functional role of NF-IL6β and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene , 2006, Nucleic acids research.

[24]  J. Stankova,et al.  Janus Kinase 2 Activation by the Platelet-Activating Factor Receptor (PAFR): Roles of Tyk2 and PAFR C Terminus1 , 2003, The Journal of Immunology.

[25]  T. van der Poll,et al.  Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. , 2004, The Journal of infectious diseases.

[26]  Qiang Tian,et al.  The C/EBP bZIP Domain Can Mediate Lipopolysaccharide Induction of the Proinflammatory Cytokines Interleukin-6 and Monocyte Chemoattractant Protein-1* , 2000, The Journal of Biological Chemistry.

[27]  Jana N Radin,et al.  β-Arrestin 1 Participates in Platelet-Activating Factor Receptor-Mediated Endocytosis of Streptococcus pneumoniae , 2005, Infection and Immunity.

[28]  E. Tuomanen,et al.  Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor , 1995, Nature.

[29]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.

[30]  S. Keely,et al.  Hypoxia-inducible Factor-dependent Regulation of Platelet-activating Factor Receptor as a Route for Gram-Positive Bacterial Translocation across Epithelia , 2010, Molecular biology of the cell.

[31]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[32]  M. Peppelenbosch,et al.  Hedgehog signaling maintains chemoresistance in myeloid leukemic cells , 2010, Oncogene.

[33]  T. van der Poll,et al.  Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor , 2008, The Journal of Immunology.

[34]  J. Derry,et al.  Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. , 2007, Immunity.

[35]  S. Sammani,et al.  Re-evaluation of Evans Blue dye as a marker of albumin clearance in murine models of acute lung injury. , 2007, Translational research : the journal of laboratory and clinical medicine.

[36]  Alistair G. Rust,et al.  Role of the transcription factor C/EBPδ in a regulatory circuit that discriminates between transient and persistent Toll-like receptor 4-induced signals , 2009, Nature Immunology.

[37]  M. Teixeira,et al.  Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice , 2010, PLoS pathogens.